Advertisement
RZLT vs ZBIO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RZLT is a Hold and ZBIO is a StrongBuy.
RZLT in downward trend: price dove below 50-day moving average on October 14, 2026
RZLT moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend. In 42 of 47 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for RZLT moved out of overbought territory on October 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 24 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RZLT as a result. In 84 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RZLT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
RZLT broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 55 of 59 cases where RZLT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for RZLT just turned positive on November 10, 2026. Looking at past instances where RZLT's MACD turned positive, the stock continued to rise in 44 of 49 cases over the following month. The odds of a continued upward trend are 90%.
Following a +10.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where RZLT advanced for three days, in 243 of 268 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.727) is normal, around the industry mean (3.498). P/E Ratio (-5.173) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. RZLT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RZLT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
ZBIO's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for ZBIO turned positive on October 20, 2026. Looking at past instances where ZBIO's MACD turned positive, the stock continued to rise in 18 of 19 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on ZBIO as a result. In 39 of 45 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
Following a +1.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZBIO advanced for three days, in 117 of 133 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
ZBIO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 20 of 27 cases where ZBIO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZBIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Aroon Indicator for ZBIO entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. ZBIO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.454) is normal, around the industry mean (3.498). P/E Ratio (-2.935) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (1666.667) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZBIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
RZLT | ZBIO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 78 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 33 Fair valued | 87 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 64 | 48 | |
P/E GROWTH RATING 1..100 | 29 | 98 | |
SEASONALITY SCORE 1..100 | 85 | 70 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RZLT's Valuation (33) in the null industry is somewhat better than the same rating for ZBIO (87). This means that RZLT’s stock grew somewhat faster than ZBIO’s over the last 12 months.
RZLT's Profit vs Risk Rating (100) in the null industry is in the same range as ZBIO (100). This means that RZLT’s stock grew similarly to ZBIO’s over the last 12 months.
RZLT's SMR Rating (98) in the null industry is in the same range as ZBIO (100). This means that RZLT’s stock grew similarly to ZBIO’s over the last 12 months.
ZBIO's Price Growth Rating (48) in the null industry is in the same range as RZLT (64). This means that ZBIO’s stock grew similarly to RZLT’s over the last 12 months.
RZLT's P/E Growth Rating (29) in the null industry is significantly better than the same rating for ZBIO (98). This means that RZLT’s stock grew significantly faster than ZBIO’s over the last 12 months.
| RZLT | ZBIO | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 73% | N/A |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 74% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 87% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 89% | 2 days ago 87% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Advances ODDS (%) | 15 days ago 90% | 2 days ago 88% |
| Declines ODDS (%) | 7 days ago 87% | 10 days ago 79% |
| BollingerBands ODDS (%) | 3 days ago 69% | 2 days ago 73% |
| Aroon ODDS (%) | N/A | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RZLT’s FA Score shows that 2 FA rating(s) are green while ZBIO’s FA Score has 0 green FA rating(s).
- RZLT’s FA Score: 2 green, 3 red.
- ZBIO’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
RZLT’s TA Score shows that 3 TA indicator(s) are bullish while ZBIO’s TA Score has 4 bullish TA indicator(s).
- RZLT’s TA Score: 3 bullish, 5 bearish.
- ZBIO’s TA Score: 4 bullish, 3 bearish.
Price Growth
RZLT (@Biotechnology) experienced а +0.25% price change this week, while ZBIO (@Biotechnology) price change was +0.70% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
RZLT is expected to report earnings on Feb 10, 2027.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
RZLT and
Correlation & Price change
A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with GRI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then GRI could also see price increases.
| Ticker / NAME | Correlation To RZLT | 1D Price Change % | ||
|---|---|---|---|---|
| RZLT | 100% | +4.09% | ||
| GRI - RZLT | 53% Loosely correlated | +5.59% | ||
| DYN - RZLT | 43% Loosely correlated | -3.76% | ||
| ENVB - RZLT | 42% Loosely correlated | +4.86% | ||
| SYRE - RZLT | 42% Loosely correlated | -4.15% | ||
| CRVS - RZLT | 41% Loosely correlated | +0.18% | ||
More | ||||
ZBIO and
Correlation & Price change
A.I.dvisor indicates that over the last year, ZBIO has been loosely correlated with REPL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBIO jumps, then REPL could also see price increases.
| Ticker / NAME | Correlation To ZBIO | 1D Price Change % | ||
|---|---|---|---|---|
| ZBIO | 100% | +0.04% | ||
| REPL - ZBIO | 41% Loosely correlated | +4.58% | ||
| KURA - ZBIO | 39% Loosely correlated | N/A | ||
| RZLT - ZBIO | 37% Loosely correlated | +4.09% | ||
| PVLA - ZBIO | 37% Loosely correlated | -3.08% | ||
| NTLA - ZBIO | 36% Loosely correlated | -7.76% | ||
More | ||||